Home > Journals > Minerva Ophthalmology > Past Issues > Minerva Oftalmologica 2016 December;58(4) > Minerva Oftalmologica 2016 December;58(4):65-9

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLES   Free accessfree

Minerva Oftalmologica 2016 December;58(4):65-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Evaluation of the efficacy of a new escin-based, multi-component formulation in reducing eyelid edema

Gianni BELCARO 1, Mark DUGALL 1, Giada MARAMALDI 2, Stefano TOGNI 2, Luca GIACOMELLI 3

1 Department of SMO Biotech, Irvine3 Labs, Circulation Sciences, University of Chieti-Pescara, Chieti, Italy; 2 Indena SpA, Milan, Italy; 3 Department of Surgical Sciences and Integrated Diagnostics, School of Medicine, University of Genoa, Genoa, Italy


PDF


BACKGROUND: The aim of this study was to evaluate the synergistic effect of different active ingredients with well-known anti-inflammatory activity and ability to stimulate skin microcirculation in attenuating the eyelid edema.
METHODS: In this randomized, vehicle-controlled study, 57 healthy subjects with lower eyelid bags were advised to apply in the periorbital region and surrounding area, 1 g of the assigned formulation twice a day for 8 weeks. The three topical products used in this study were: vehicle (no active ingredients); escin 0.2% cream; a multi-component cream (Phytosome®) composed by escin β-sitosterol, Zanthoxylum bungeanum fruit extract, ethyl ximenynate and ruscogenins. Each individual was subjected to several non-invasive examinations (elastosonography, laser Doppler flowmetry, thermography, transcutaneous tension of oxygen test, infra-orbital 3D reconstruction) at the following time period: at inclusion, to evaluate the basal conditions of the subject prior to the beginning of the study, after 4 weeks and 8 weeks to evaluate the efficacy of the formulation tested.
RESULTS: The 57 individuals recruited in this study were randomly assigned to either vehicle group (N.=18), escin 0.2% cream group (N.=19) or multi-component cream group (N.=20). The escin-based multi-component cream showed beneficial effects in all the microcirculatory parameters of the lower eyelid area evaluated at 4 and 8 weeks. Moreover, the multi-component formulation resulted also to be effective in reducing lower eyelid puffiness at 4 weeks, with respect to the condition at inclusion.
CONCLUSIONS: Our pilot study showed the efficacy of an escin-based, multi-component cream in improving under-eyes skin microcirculation and reducing the eyelid edema, suggesting a potential beneficial role in alleviating post-operative eyelid edema.

top of page